Clinical Trial

Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis

Name: Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis — clinical trial record (NCT07722507)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: UPWARD

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study will explore how adults in Japan with pulmonary fibrosis decide whether to continue or discontinue antifibrotic therapy after experiencing antifibrotic therapy-related adverse events.

Trial Details

NCT Number	NCT07722507
Lead Sponsor	Bristol-Myers Squibb
Conditions	Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Enrollment	40 participants
Start Date	2026-08-01
Primary Completion	2027-05-31 (estimated)
Study Completion	2027-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-23